No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
519447 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
183 |
4. Check minimum number of eventsNone |
183 |
5. Include endpointsNone |
183 |
6. Filter based on genotype QC (FinnGen only) |
183 |
Control definitions (FinnGen only)
- Control conditions
- not Q17_CLEFT_PALATE_EXCLUDE
Extra metadata
- First used in FinnGen datafreeze
- DF7
Similar endpoints
↥List of similar endpoints to
Cleft hard palate NOS
based on the number of shared cases.
Similar with more cases:
- Cleft palate
- Cleft lip, lip and palate or palate
- Congenital malformations, deformations and chromosomal abnormalities
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2587 | 1496 | 1087 |
| Only index persons | 2115 | 1232 | 883 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.04 | 0.03 |
| Only index persons | 0.04 | 0.05 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 4.64 | 4.10 | 5.17 |
| Only index persons | 6.77 | 6.27 | 7.47 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 183 | 130 | 53 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.02 |
| Median age at first event (years) | 15.18 | 15.92 | 13.37 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 169
- Matched controls
- 1687
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q35.1
ICD-10 Finland
Cleft hard palate
+∞
235.5
166
*
7490A
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS COMPLETA]
+∞
60.0
54
*
74900
ICD-8 Finland
Cleft palate and cleft lip, Cleft palate
+∞
47.1
43
*
4362
FHL
Nozzle reconstruction
547.9
44.4
42
*
4122
FHL
Tympanostomy (tympanic tube)
22.8
36.0
53
33
4364
FHL
Pharyngeal tongue plastic
+∞
31.2
29
*
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
16.2
31.0
52
45
SJX10
NOMESCO Finland
Short check-up visit for orthodontisk therapy
12.6
30.4
58
67
SBB10
NOMESCO Finland
Teeth copy
10.1
29.8
66
101
Q35.9
ICD-10 Finland
Cleft palate, unspecified
+∞
29.0
27
*
Q37.1
ICD-10 Finland
Cleft hard palate with unilateral cleft lip
333.7
28.7
28
*
SAA04
NOMESCO Finland
Special inverstigation of mouth
13.6
28.1
51
52
7490B
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate[PALATOSCHISIS INCOMPLETA]
+∞
26.8
25
*
3812A
ICD-9 Finland
Nonsuppurative otitis media and Eustachian tube disorders, Chronic mucoid otitis media
16.0
23.1
38
30
Q35.3
ICD-10 Finland
Cleft soft palate
+∞
22.4
21
*
EB1MA
NOMESCO Finland
Cephalometry with X-ray
11.8
22.0
42
46
Q35.71
ICD-10 Finland
Submucous cleft palate
+∞
19.1
18
*
SJC50
NOMESCO Finland
Removal of orthodontisk device with at least 7 brackets
12.9
18.5
33
31
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
8.7
18.2
41
60
H65.3
ICD-10 Finland
Chronic mucoid otitis media
10.4
17.0
34
40
EEC05
NOMESCO Finland
Le Fort I osteotomy
+∞
17.0
16
*
EHC40
NOMESCO Finland
Correction of submucous cleft palate
+∞
17.0
16
*
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
187.8
16.8
17
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
11.9
16.3
30
30
SJD00
NOMESCO Finland
Removal or reattacment of arrow in fixed orthodontisk device
9.1
16.2
35
47
4368
FHL
Closing the fistula of the mouth
+∞
14.8
14
*
EHC10
NOMESCO Finland
Plastic repair of oronasal or oroantral fistula of palate
+∞
14.8
14
*
SJB00
NOMESCO Finland
Fitting of loose orthodontic device with user information
8.8
14.3
31
42
EBB10
NOMESCO Finland
Insertion of dental implant
31.2
13.2
17
6
Z2221
NOMESCO Finland
Medical doctor
3.6
12.8
76
315
4361
FHL
Lip plastic or reconstruction due to cleft lip
+∞
12.7
12
*
Q37.0
ICD-10 Finland
Cleft hard palate with bilateral cleft lip
140.0
12.6
13
*
K00.00
ICD-10 Finland
Hypodontia
14.0
12.0
20
16
ENC80
NOMESCO Finland
Plastic operation of soft palate for voice distubance
+∞
11.6
11
*
SAA03
NOMESCO Finland
Extended examination of mouth
3.2
11.5
107
597
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
37.9
11.5
14
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
7.9
11.4
26
38
1450
FHL
Otomicroscopy
27.2
11.4
15
6
SJD30
NOMESCO Finland
Demanding attachment of arrow to fixed orthodontisk device
9.9
11.2
22
25
ZXD10
NOMESCO Finland
Scheduled procedure
3.2
11.1
80
373
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
19.5
11.0
16
9
K07.25
ICD-10 Finland
Anomalies of dental arch relationship
10.3
10.9
21
23
ZXB10
NOMESCO Finland
Medial
64.2
10.8
12
*
SJD20
NOMESCO Finland
Attachment of modifiable arrow of fixed orthodontisk device
8.0
10.7
24
34
EAB30
NOMESCO Finland
Correction of cleft lip
117.0
10.5
11
*
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
20.4
10.5
15
8
ZXA10
NOMESCO Finland
Bilateral
4.0
10.2
45
142
SJA01
NOMESCO Finland
Estimation of need for orthodontic care
42.8
10.1
12
*
SJD40
NOMESCO Finland
Fixation of ready made palatinal or lingual arrow
7.2
10.0
24
38
74920
ICD-8 Finland
Cleft palate and cleft lip, Cheilognathopalatoschisis unilateralis
105.7
9.5
10
*
7492A
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate with cleft lip[CHEILOPALATOSCHISIS UNILATERALIS COMPLETA]
105.7
9.5
10
*
EHC30
NOMESCO Finland
Reconstruction of palate
+∞
9.5
9
*
SJA03
NOMESCO Finland
Demanding plan for orthodontic care
+∞
9.5
9
*
4451
FHL
Guitar cutting
4.8
9.4
32
78
ECB40
NOMESCO Finland
Surgical treatment of fracture of alveolus
52.8
8.8
10
*
SJA04
NOMESCO Finland
Very demanding plan for orthodontic care
94.6
8.5
9
*
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
47.2
7.8
9
*
EBB15
NOMESCO Finland
Insertion of dental implant abutment
26.4
7.7
10
*
UDC00
NOMESCO Finland
Ear microscopy
4.7
7.5
25
60
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
83.6
7.5
8
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
2.5
7.5
91
543
4365
FHL
Correction of nasal deformity
+∞
7.3
7
*
3842A
ICD-9 Finland
Other disorders of tympanic membrane, Perforation of tympanic membrane
+∞
7.3
7
*
4141
FHL
Myringoplasty (also for reasons other than inflammation)
+∞
7.3
7
*
SJB60
NOMESCO Finland
External device grinding and adaptation
6.6
7.3
18
30
ZXE10
NOMESCO Finland
More than one and less than three hours
2.6
7.2
63
314
SJD10
NOMESCO Finland
Attachment of arrow to fixed orthodontisk device
5.3
7.1
21
44
K07.14
ICD-10 Finland
Retrognaty, maxillary
17.6
6.8
10
6
R1260
NOMESCO Finland
Evaluation of communicative skills
23.6
6.7
9
*
J01DA06
ATC
[U] cefuroxime; systemic
3.1
6.6
37
139
ECB17
NOMESCO Finland
Operation for cleft gingiva
72.5
6.5
7
*
EBA10
NOMESCO Finland
Surgical removal of tooth
2.7
6.4
48
216
EB1WA
NOMESCO Finland
NA
18.9
6.3
9
5
EH1JB
NOMESCO Finland
Functional examination of palate
+∞
6.3
6
*
Q36.9
ICD-10 Finland
Cleft lip, unilateral
+∞
6.3
6
*
SPB10
NOMESCO Finland
Production of temporary crone to tooth
+∞
6.3
6
*
7492C
ICD-9 Finland
Cleft palate and cleft lip, Cleft palate with cleft lip[CHEILOPALATOSCHISIS BILATERALIS COMPLETA]
+∞
6.3
6
*
Q35
ICD-10 Finland
Cleft palate
+∞
6.3
6
*
4121
FHL
Tympanic puncture or parasentosis in general anesthesia or operating room
8.2
6.3
13
17
UDQ12
NOMESCO Finland
Flexible laryngoscopy
6.5
6.2
15
25
Z01.1
ICD-10 Finland
Examination of ears and hearing
3.3
6.2
31
108
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026389) Candida sp identified in Specimen by Organism specific culture
8
16
5.18
3.08
1.4
1.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
7
15
4.81
2.62
1.0
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
0
62
0.00
2.27
0.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
11
43
2.66
2.14
8.1
26.8
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
36
532
0.60
2.04
2.3
2.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
27
160
1.81
1.95
1.9
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
27
166
1.73
1.74
1.5
1.5
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
23
138
1.76
1.61
1.2
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
44
313
1.53
1.60
3.1
3.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
35
490
0.65
1.51
2.1
2.2
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
15
80
1.95
1.49
6.9
17.3
mmol/l
0.6
1.2
—
9
67
(40768793) Breast Pathology biopsy report
0
37
0.00
1.36
0.0
1.2
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
6
24
2.55
1.31
1.0
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
35
477
0.67
1.31
1.6
1.8
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
56
2.03
1.25
1.1
1.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
8
39
2.10
1.17
1.3
16.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
115
1021
1.34
1.10
3.9
4.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
101
1132
0.76
1.04
3.6
3.8
mmol/mol
36.6
37.1
0.24
94
1085
(3012544) pH of Venous blood
16
99
1.68
1.04
5.5
11.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
38
287
1.41
1.03
1.5
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
127
1378
0.74
1.02
4.0
4.5
mu/l
1.8
1.7
0.17
120
1299
(3019550) Sodium [Moles/volume] in Serum or Plasma
150
1395
1.42
1.01
8.9
10.2
mmol/l
139.4
139.5
0.20
145
1347
(3032080) INR in Blood by Coagulation assay
45
354
1.36
0.96
4.3
5.9
inr
1.0
1.1
—
8
118
(3023103) Potassium [Moles/volume] in Serum or Plasma
150
1400
1.40
0.95
9.0
10.2
mmol/l
3.9
3.9
0.05
143
1346
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
118
1285
0.77
0.90
3.1
3.2
mmol/l
5.6
5.6
0.16
110
1200
(3014007) Fractional oxyhemoglobin in Arterial blood
8
42
1.95
0.90
11.8
16.3
%
96.7
94.1
—
8
42
(3015736) pH of Urine
67
565
1.29
0.88
2.8
3.1
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
8
43
1.90
0.88
11.8
15.9
%
0.7
0.7
—
8
43
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
11
64
1.76
0.88
1.6
1.5
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
8
44
1.85
0.87
11.8
15.6
%
1.0
1.5
—
8
44
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
126
1357
0.77
0.84
3.3
3.3
mmol/l
3.0
2.8
2.18
114
1289
(3042936) Bacteria identified in Isolate by Culture
23
165
1.45
0.83
1.9
2.3
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
0
25
0.00
0.79
0.0
1.0
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
82
718
1.26
0.78
4.3
4.5
estimate
0.0
0.0
0.00
12
150
(3019897) Erythrocyte distribution width [Ratio] by Automated count
5
24
2.11
0.75
2.2
1.5
%
13.0
13.3
—
5
24
(3009261) Glucose [Presence] in Urine by Test strip
83
731
1.25
0.75
2.9
3.2
estimate
0.0
0.0
0.00
12
143
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
46
377
1.29
0.74
1.5
1.5
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
56
1.64
0.73
1.0
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
7
39
1.83
0.73
1.1
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
40
1.78
0.72
1.0
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
10
61
1.68
0.70
1.0
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
80
707
1.23
0.69
3.6
4.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
12
78
1.58
0.67
3.3
5.9
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
51
430
1.26
0.66
2.6
3.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
81
720
1.22
0.65
2.9
3.2
estimate
0.0
0.0
0.00
12
144
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
13
87
1.53
0.65
8.5
13.4
mmol/l
25.0
24.8
0.10
13
87
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
13
187
0.67
0.65
1.8
1.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
104
0.56
0.64
1.0
1.9
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
18
242
0.72
0.63
1.1
1.3
u/ml
25.5
11.1
—
10
100
(3003338) MCHC [Mass/volume]
150
1425
1.29
0.63
11.0
13.0
g/l
334.2
334.0
0.11
143
1420
(3000991) Gas panel - Venous blood
13
88
1.51
0.62
11.9
14.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
52
443
1.24
0.62
2.0
2.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
0
20
0.00
0.60
0.0
1.4
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
127
1346
0.82
0.58
2.9
3.1
mmol/l
1.4
1.5
0.84
116
1284
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
120
1278
0.82
0.57
2.8
2.9
mmol/l
1.3
1.2
0.79
109
1215
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
19
248
0.74
0.56
1.2
1.8
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
82
1.50
0.56
1.0
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
9
60
1.53
0.55
1.1
1.1
—
11.8
—
0
10
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
12
169
0.69
0.55
1.5
1.5
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
52
452
1.21
0.51
3.9
5.7
g/l
36.1
37.3
0.77
47
430
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
24
298
0.78
0.50
1.5
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
54
472
1.20
0.50
3.2
3.6
e6/l
24.1
96.9
0.60
35
300
(36304419) Bacteria [Presence] in Urine
41
349
1.23
0.49
2.5
2.9
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
105
975
1.18
0.49
3.5
4.1
—
363.5
—
0
10
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
116
0.68
0.47
1.4
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
60
671
0.84
0.47
10.0
8.3
e9/l
0.0
0.0
0.71
49
537
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
40
462
0.83
0.45
1.2
1.4
u/ml
0.6
2.4
—
9
108
(3052851) Hemolysis interference index of Serum or Plasma
5
31
1.63
0.43
1.8
2.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
129
1351
0.85
0.43
3.0
3.2
mmol/l
4.8
4.7
1.35
117
1292
(3013826) Glucose [Moles/volume] in Serum or Plasma
80
733
1.16
0.42
4.1
5.6
mmol/l
6.2
6.3
0.08
72
640
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
20
248
0.78
0.42
1.1
1.3
iu/ml
34.8
16.6
—
5
74
(3004588) Protein electrophoresis panel - Serum or Plasma
5
33
1.53
0.41
4.0
2.4
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
0
15
0.00
0.41
0.0
2.2
—
55.5
—
0
9
(3022806) Fractional oxyhemoglobin in Capillary blood
0
15
0.00
0.41
0.0
1.4
—
91.8
—
0
15
(3016018) Differential panel - Cerebral spinal fluid
0
16
0.00
0.41
0.0
3.2
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
16
0.00
0.41
0.0
2.0
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
17
0.00
0.41
0.0
6.4
—
99.3
—
0
17
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
34
1.48
0.40
1.0
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
16
124
1.32
0.40
1.6
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
38
436
0.84
0.40
2.4
2.6
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
79
854
0.87
0.39
9.2
8.8
e9/l
4.1
4.0
0.16
69
753
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
110
1162
0.87
0.39
3.5
4.0
pmol/l
13.9
14.4
1.67
102
1075
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
36
1.40
0.38
1.0
1.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
8
114
0.69
0.38
1.4
1.5
mu/l
297.5
336.0
—
8
104
(3007164) IgA [Mass/volume] in Serum or Plasma
37
424
0.84
0.38
1.3
1.5
g/l
1.8
2.2
1.50
24
267
(3003694) ABO and Rh group [Type] in Blood
54
595
0.87
0.34
1.9
1.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
39
343
1.17
0.34
3.4
2.4
ng/l
42.5
37.9
0.07
18
143
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
27
315
0.83
0.34
1.3
1.9
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
6
47
1.29
0.32
2.3
2.6
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
6
47
1.29
0.32
6.2
12.6
g/l
124.0
132.4
—
6
47
(3030467) Casts [#/volume] in Urine by Automated count
39
345
1.17
0.32
2.6
2.9
e6/l
0.4
0.3
0.40
30
249
(40761511) CBC panel - Blood by Automated count
163
1591
1.22
0.32
8.5
9.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
131
0.75
0.32
1.0
1.0
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
10
131
0.75
0.32
2.2
1.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
97
1025
0.89
0.32
4.2
3.6
mm/h
10.8
8.4
0.81
91
953
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
21
176
1.22
0.30
3.5
3.5
ng/l
1080.5
664.7
0.46
15
142
(3023511) Choriogonadotropin [Units/volume] in Urine
8
106
0.74
0.30
1.1
1.2
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
8
107
0.74
0.30
2.6
3.3
pmol/l
4.8
4.9
—
8
97
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
92
972
0.89
0.29
7.0
6.1
u/l
81.3
77.6
0.29
85
910
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
13
103
1.28
0.29
3.3
5.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
9
119
0.74
0.28
1.6
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
12
150
0.79
0.28
1.5
1.5
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
12
150
0.79
0.28
1.5
1.5
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
12
150
0.79
0.28
1.5
1.5
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
12
150
0.79
0.28
1.5
1.5
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
17
203
0.82
0.27
1.2
1.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
67
718
0.89
0.27
7.9
6.0
%
55.4
55.2
0.07
61
683
(3002030) Lymphocytes/100 leukocytes in Blood
68
728
0.90
0.27
8.2
6.1
%
30.6
30.6
0.00
63
694
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
11
86
1.30
0.27
2.5
3.1
%
14.4
20.4
—
5
30
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
5
71
0.70
0.26
2.8
2.0
—
89.6
—
0
27
(40760892) CBC W Ordered Manual Differential panel - Blood
32
359
0.87
0.26
4.3
4.1
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
9
75
1.21
0.25
12.7
15.8
mmol/l
1.1
1.4
—
9
69
(3002256) Pathology report gross observation
19
161
1.20
0.25
1.1
1.2
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
65
695
0.90
0.25
8.6
6.6
%
8.2
8.0
0.28
60
661
(3006504) Eosinophils/100 leukocytes in Blood
65
695
0.90
0.25
8.2
6.2
%
2.6
2.7
0.16
60
654
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
37
333
1.14
0.25
1.9
2.0
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
27
305
0.87
0.24
1.6
2.0
u/l
198.6
404.6
0.45
22
293
(3019225) pH of Specimen
7
93
0.74
0.23
3.4
4.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
29
258
1.15
0.23
2.9
3.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
69
731
0.91
0.22
7.9
6.2
e9/l
0.6
0.5
0.32
63
647
(3027945) Reticulocytes/100 erythrocytes in Blood
8
102
0.77
0.21
3.9
4.7
%
1.8
1.6
—
8
95
(3013115) Eosinophils [#/volume] in Blood
72
761
0.91
0.21
7.8
6.8
e9/l
0.2
0.2
0.18
64
686
(4062490)
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(4146454)
0
10
0.00
0.21
0.0
2.8
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
10
0.00
0.21
0.0
1.0
—
147.5
—
0
10
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
3.7
—
12.9
—
0
10
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
5.4
—
1.7
—
0
10
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
11
134
0.81
0.21
2.3
1.7
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
20
229
0.86
0.21
3.1
3.3
mg/l
106.3
104.7
0.01
15
152
(3011897) Casein IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
12
0.00
0.21
0.0
1.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
13
0.00
0.21
0.0
2.4
—
864.8
—
0
6
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
42
386
1.11
0.21
2.5
3.0
e6/l
19.2
39.4
0.77
32
286
(3022096) Basophils/100 leukocytes in Blood
63
669
0.91
0.21
8.6
6.4
%
0.7
0.6
0.49
58
627
(3016879) Cocaine [Presence] in Urine
12
144
0.82
0.20
1.1
1.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
49
455
1.11
0.20
8.8
7.0
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
6
51
1.18
0.19
1.8
2.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
56
525
1.10
0.19
6.8
8.4
mmol/l
1.2
1.2
0.06
51
455
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
16
185
0.85
0.19
1.4
2.4
u/l
2355.0
3737.8
—
7
83
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
23
205
1.14
0.18
2.7
3.0
e6/l
1.0
0.7
—
10
112
(3001019) Free T4 and TSH panel - Serum or Plasma
13
110
1.20
0.17
1.1
1.6
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
62
1.13
0.17
1.3
1.4
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
73
765
0.92
0.17
7.5
6.1
e9/l
2.1
2.0
0.66
67
691
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
20
225
0.88
0.17
2.1
2.1
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
10
120
0.82
0.17
1.6
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
29
317
0.90
0.16
2.2
2.3
mg/l
1.1
1.0
0.08
20
229
(3022948) Iron [Moles/volume] in Serum or Plasma
15
172
0.86
0.16
2.3
2.4
umol/l
14.0
14.2
0.03
15
160
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
71
1.13
0.16
1.1
1.5
—
—
—
0
0
(3036489) Thrombin time
8
71
1.13
0.16
1.5
4.2
s
24.3
20.9
—
8
62
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
22
197
1.13
0.16
2.7
3.1
e6/l
4.6
2.3
—
10
103
(3006315) Basophils [#/volume] in Blood
70
733
0.93
0.16
7.7
6.2
e9/l
0.0
0.0
0.37
63
647
(3022621) pH of Urine by Test strip
6
79
0.75
0.16
2.7
2.3
—
—
—
0
0
(4035726)
10
83
1.22
0.16
1.2
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
11
93
1.19
0.15
3.6
2.0
nmol/l
10.9
13.1
0.32
11
84
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
56
531
1.08
0.15
1.6
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
152
1495
1.10
0.14
11.2
11.8
%
39.5
40.4
0.79
126
1265
(3028026) IgM [Mass/volume] in Serum or Plasma
8
97
0.82
0.14
2.9
1.8
g/l
2.5
1.2
—
8
91
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
97
0.82
0.14
2.0
2.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
38
355
1.09
0.14
6.2
6.6
—
—
—
0
0
(3013512) EKG study
22
242
0.90
0.14
5.4
2.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
153
1506
1.10
0.14
10.1
10.2
mg/l
23.2
20.8
0.32
120
1143
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
12
138
0.86
0.13
1.7
1.6
—
—
—
0
0
(3000492) Spirometry study
16
142
1.14
0.13
1.4
1.5
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
51
536
0.93
0.12
1.8
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
31
332
0.92
0.12
1.5
1.6
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
125
0.87
0.10
1.5
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
26
242
1.09
0.10
1.3
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
15
135
1.12
0.10
1.3
1.3
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
5
47
1.07
0.09
1.2
1.3
—
64.0
—
0
5
(40768443) Skin Pathology biopsy report
5
47
1.07
0.09
1.4
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
5
48
1.04
0.09
1.0
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
55
569
0.95
0.08
2.9
2.6
nmol/l
69.2
72.1
0.30
49
524
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
6
71
0.84
0.08
1.2
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
8
75
1.07
0.07
1.5
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
16
147
1.10
0.07
1.1
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
9
87
1.04
0.07
1.2
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
10
89
1.13
0.07
2.2
2.3
—
29.7
—
0
7
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
58
563
1.04
0.07
2.8
3.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
11
121
0.90
0.06
1.5
1.5
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
11
121
0.90
0.06
1.5
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
12
131
0.91
0.06
2.9
2.8
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
10
110
0.90
0.05
1.4
1.5
iu/l
11.6
17.2
—
10
89
(36660697) Celiac disease serology panel - Serum
19
179
1.07
0.05
1.1
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
37
383
0.96
0.05
2.8
3.2
estimate
0.0
0.0
0.50
12
150
(3044889) 12 lead EKG panel
80
786
1.03
0.04
2.6
2.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
10
108
0.92
0.03
1.1
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
54
530
1.03
0.02
2.4
2.0
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
128
1270
1.03
0.02
7.7
7.7
ml/min/173m2
100.0
97.7
0.51
99
996
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
156
1551
1.04
0.02
8.3
8.0
u/l
26.0
25.7
0.08
148
1502
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
13
138
0.94
0.02
2.4
2.5
%
21.2
24.2
0.46
13
120
(3009508) Creatinine [Moles/volume] in Urine
34
331
1.03
0.02
2.9
3.3
mmol/l
8.6
8.4
0.05
29
298
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
54
547
0.98
0.01
1.6
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
19
194
0.98
0.00
2.3
3.0
ng/l
1072.9
295.4
—
9
107
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
121
0.99
0.00
1.1
1.3
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
23
234
0.98
0.00
3.6
4.0
mg/mmol
10.1
14.0
0.22
16
154
(3028300) Cannabinoids [Presence] in Urine
16
159
1.01
0.00
1.1
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
19
189
1.01
0.00
1.8
1.5
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
38
384
0.99
0.00
2.6
3.1
mmol/l
2.4
2.4
0.04
31
347
(3026008) Bacteria identified in Urine by Culture
41
409
1.00
0.00
2.2
2.4
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
12
123
0.97
0.00
1.0
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
16
157
1.02
0.00
1.1
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
16
157
1.02
0.00
1.1
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
16
157
1.02
0.00
1.1
1.5
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
48
477
1.01
0.00
7.2
8.2
mmol/l
1.2
1.2
0.09
41
440
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
143
1435
0.98
0.00
4.0
4.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
66
657
1.01
0.00
1.8
2.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
11
115
0.95
0.00
2.7
3.0
ug/l
1.5
1.5
0.00
11
104
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
55
0.91
0.00
1.2
1.5
—
—
—
0
0
(4024509)
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
3.2
—
16.3
—
0
6
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
9
0.00
0.00
0.0
1.7
—
31.8
—
0
9
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
9.3
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
6
59
1.02
0.00
1.7
4.9
%
140.2
159.0
—
6
59
(21491868) Cryoglobulin [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
213.2
—
0
5
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.6
—
714.0
—
0
7
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
0
7
0.00
0.00
0.0
2.7
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.3
—
49.7
—
0
7
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
0
7
0.00
0.00
0.0
1.3
—
0.2
—
0
7
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
50
1.00
0.00
2.0
1.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
5
0.00
0.00
0.0
1.8
—
123.6
—
0
5
(3024471) HLA-A [Type]
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1002224) Polysomnography panel
7
70
1.00
0.00
1.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
3.2
—
125.0
—
0
5
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008898) HLA-B27 [Presence]
9
93
0.97
0.00
1.1
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3017704) Immunofixation for Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
10.9
—
0
9
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.8
—
2.0
—
0
5
(3024932) HLA-DR beta [Type]
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
10
100
1.00
0.00
2.0
2.7
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(4010399)
8
84
0.95
0.00
1.1
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
60
1.00
0.00
1.3
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
40
400
1.00
0.00
1.5
1.7
pmol/l
91.1
97.8
0.62
23
211
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
6.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045462) Protein/Creatinine [Ratio] in Urine
0
8
0.00
0.00
0.0
7.1
—
134.8
—
0
8
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
6
0.00
0.00
0.0
12.2
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
102.5
—
0
8
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000012) Reticulocyte production index
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035947) Staphylolysin Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
8
87
0.92
0.00
1.4
1.6
u/l
5.9
7.8
—
8
67
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
8
84
0.95
0.00
2.6
3.5
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
61
0.98
0.00
1.5
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CLEFT_HARD_PALATE_NOS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have Q17_CLEFT_HARD_PALATE_NOS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: Q17_CLEFT_HARD_PALATE_NOS – Cleft hard palate NOS
GWS hits: 3
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data